Here's What Will Drive AbbVie's Top-line Growth in 2026

ABBV sees 2026 revenues rising to $67B as Rinvoq and Skyrizi drive growth, with neuroscience gains offsetting Humira erosion and oncology headwinds....

Zacks Investment Research - 2/10/2026 10:35:30 AM More News for ABBV
Stock Analysis for ABBV
Related Stocks: